Information

2008/08/01

GNI Announces Restructuring to Streamline Operation and to Reduce Cost; CEO Luo Succeeds President

2008/08/01

Notice of Stock Issuance in Private Placement Offering

2008/07/31

Pharma Focus Asia Published an article “Breaking Down Borders Asian biotechnology industry” authorized by Dr. Ying Luo in its July issue http://www.pharmafocusasia.com/magazine/

2008/07/30

New Ubiquitin-Mediated Protein Degradation Mechanism Published by Scientists in Shanghai

2008/07/29

Amendment of Share Purchase Commitment Agreement with Evo Fund

2008/07/25

Notification of major shareholder Change

2008/07/22

Notice of Granting Stock Option to Board of Directors and Corporate Auditors

2008/07/16

EpiCept and GNI Form Partnership to Develop Liver Disease Drug in Asia

2008/07/15

GNI Announces the Conclusion of the Share Purchase Agreement

2008/06/30

GNI Announces Election of New Directors and Auditor